Recent Posts
- MRM Health’s Lead Candidate MH002 Granted Fast Track Designation by U.S. FDA for the Treatment of Mild-to-Moderate Ulcerative Colitis
- MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline
- EMIH response to the European Commission call for evidence on the EU Biotech Act
- The “Microbiome Times Forum” brought together key experts to shape the future of microbiome innovation in the European Union
- The European Microbiome Innovation for Health Association Welcomes 13 New Members, Strengthening Europe’s Leadership in Microbiome Innovation
Recent Comments
No comments to show.